Navigation Links
Dermatologists Release Psoriasis Care Guidelines
Date:5/30/2008

Biologic use is expected to enhance quality of treatment and patient safety

FRIDAY, May 30 (HealthDay News) -- The use of biologics is the focus of new guidelines for the management of mild to severe psoriasis and psoriatic arthritis released by the American Academy of Dermatology (ADA).

Biologics -- given by injection or infusion -- are systemic medications that pinpoint immune responses involved with psoriasis and psoriatic arthritis.

About 6 million to 7 million Americans have psoriasis, and between 300,000 and 750,000 have psoriatic arthritis. The new guidelines, based on an analysis of scientific studies of the conditions, were published in the May issue of the Journal of the American Academy of Dermatology.

"As a result of the impartial analysis of the most current research, physicians now have evidence-based guidelines which will help enhance the quality of care for patients and ultimately their safety," ADA President Dr. C. William Hanke said in a prepared statement.

"The guidelines for psoriasis and psoriatic arthritis, which focus on the use of biologics, are the first phase of the academy's efforts. The academy is currently working on the second phase of these guidelines, which will provide evidence-based advice for the management of psoriasis with topical therapies, ultraviolet light therapy, and systemic non-biologic therapies for psoriasis."

The new guidelines advise that topical treatments are appropriate for patients who are good candidates for localized therapy. But, in many cases, topical treatments should not be used exclusively to treat psoriasis if patients would benefit from a combination of systemic and/or phototherapy treatments.

Currently, five biologics are approved by the U.S. Food and Drug Administration for treatment of psoriasis, and three of those five are approved for psoriatic arthritis.

Because biologics target the immune system, it's important to use all approaches, including vaccination, to prevent infection, the guidelines state. However, once biologic therapy has started, patients should avoid vaccinations with live vaccines and consult their dermatologist before receiving vaccination of any kind.

Patients undergoing biologic therapy need to have periodic re-evaluations by their dermatologist to check for the development of new symptoms, including infections and potential cancers.

"Regardless of the therapy that is used to treat psoriasis or psoriatic arthritis, patients need to be in constant contact with their dermatologists to report any unusual side effects or fluctuations in their condition that may require an adjustment in their medications or indicate the onset of psoriatic arthritis or another secondary medical condition," Hanke said. "These guidelines should help further the understanding of the current psoriasis therapies and help enhance the overall health and quality of life of patients."

More information

The U.S. National Institute of Arthritis and Musculoskeletal and Skin Diseases has more about psoriasis.



-- Robert Preidt



SOURCE: American Academy of Dermatology, news releaes, May 21, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Dermatologists identify North Texas leishmaniasis outbreak
2. Dermatologists Warn Fitness Enthusiasts: Dont Let Exercise-Related Skin Problems Outweigh the Benefits of Physical Activity
3. Dont Pout About Irritated Lips: Dermatologists Can Offer Top Tips to Help Keep Lips in Tip-Top Shape
4. Dont Let Hair Loss Tangle You Up: Dermatologists Can Identify Common Hair Disorders and Offer Solutions
5. New Technology and Improved Techniques Arm Dermatologists With Tools to Minimize Facial Scars From Skin Cancer Surgery
6. New Studies Support Dermatologists Recommendation: Self-Exams, Screenings Vital for Detecting Skin Cancer
7. New Jersey Dermatologists Gear Up for Fifth Season of Play Safe in the Sun at LPGAs Sybase Classic to Urge Outdoor Enthusiasts to Protect Skin
8. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
9. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
10. First New York/New Jersey Health Care Report Card Released
11. Cleveland Clinic Press Releases Journal-Writing Book Write for Life: Healing Body, Mind, and Spirit Through Journal Writing by Sheppard B. Kominars, Ph.D.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... ... Assili, announce that they are now offering treatments for sleep apnea and TMJ ... dental offices. Sleep apnea , specifically the obstructive type, is increasingly being ...
(Date:3/24/2017)... ... 2017 , ... The law firm of Enea, Scanlan & Sirignano, LLP, ... resident Lauren C. Enea has joined the firm as an associate attorney. Ms. Enea, ... in elder law, Medicaid planning and applications, and Wills, Trusts and Estates. Samantha ...
(Date:3/24/2017)... ... March 24, 2017 , ... Gastro Health ... partnership to prep patients for colonoscopy at the HyGIeaCare® Center that is to ... Miami, FL. , The HyGIeaCare® Prep, cleared by the U.S. Food ...
(Date:3/24/2017)... , ... March 24, 2017 , ... ... first Certified Medical Reiki™ Master in Frederick, MD. Judy says, “I am passionate ... during what is often a very difficult and challenging time.” , A Certified ...
(Date:3/24/2017)... ... 2017 , ... “End Time GPS”: a dauntless and enlightened study of ... GPS” is the creation of published author, Wesley Gerboth, a World War II veteran, ... space-vehicle projects. Now, at age ninety-one, he shares the Wisdom God bestowed upon him ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... Research and Markets has announced the addition of the ... offering. ... is very strong with a total of 97 drug candidates. Pharma giant ... are involved in the development of the IPF therapeutics. The IPF pipeline ... stage, 15 are in Phase II stage, 12 are in Phase I ...
(Date:3/24/2017)... Global Ampoules Market report provides ... applications and industry chain structure. The Ampoules market analysis ... competitive landscape analysis, and major regions, development status. ... ... providing 10 company profiles and 183 tables and figures ...
(Date:3/24/2017)... March 24, 2017  GenomeDx Biosciences today announced that ... and Decipher® Prostate Cancer Classifier tests will be presented ... Urology (EAU) Congress held March 24 to 28, 2017 ... EAU Congress is Europe,s largest ... in the urological field. The abstract titled ...
Breaking Medicine Technology: